111 research outputs found
Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
Get PDFBlockade of the renin-angiotensin system (RAS) is well recognized as an essential therapy in hypertensive, heart, and kidney diseases. There are several classes of drugs that block the RAS; these drugs are known to exhibit antifibrotic action. An analysis of the molecular mechanisms of action for these drugs can reveal potential differences in their antifibrotic roles. In this review, we discuss the antifibrotic action of RAS blockade with an emphasis on the potential importance of angiotensin I-converting enzyme (ACE) inhibition associated with the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP)
Studying young recipients of alcohol marketing : Two research paradigms and their possible consolidation
Get PDFPeer reviewe
Studies of fentanyl-supplemented anaesthesia: Effect of naloxone on the circulation and respiration
No full text
Frightening or Foolish? Gendered Perceptions of Public Intoxication Among Youths and Adults in Norway and Finland
No full textA double-blind study of the speed of onset of analgesia following intramuscular administration of ketorolac tromethamine in comparison to intramuscular morphine and placebo
No full text
Propacetamol and diclofenac alone and in combination for analgesia after elective tonsillectomy
No full text- …
